Patents Represented by Attorney Anthony J. Franze
  • Patent number: 4460775
    Abstract: Compounds of the formula: ##STR1## wherein R is H or ##STR2## and n is 0 or 1 are useful as angiotensin I converting enzyme inhibitors.
    Type: Grant
    Filed: August 9, 1979
    Date of Patent: July 17, 1984
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: David E. Portlock
  • Patent number: 4442038
    Abstract: N-(4-phenylcyclohexyl)glycines of the formula: ##STR1## and salts thereof wherein R is H or lower alkyl and R.sub.1 is hydrogen or benzoyl are useful as angiotensin I converting enzyme inhibitors.
    Type: Grant
    Filed: September 17, 1982
    Date of Patent: April 10, 1984
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: James R. Skuster
  • Patent number: 4439608
    Abstract: 2-[2-(5-Phenylfurfurylamino)ethyl]pyridines are useful as antihypertensive agents.
    Type: Grant
    Filed: June 4, 1982
    Date of Patent: March 27, 1984
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: Stanford S. Pelosi, Jr., Chia-Nien Yu
  • Patent number: 4439429
    Abstract: 5-(p-Chlorophenyl)-2-furaldehyde oxime is useful in treating systemic mycotic infections.
    Type: Grant
    Filed: October 30, 1981
    Date of Patent: March 27, 1984
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: Joseph E. Gray
  • Patent number: 4424367
    Abstract: 5-(4-Aminophenyl)-2-thiophenecarboximidamide hydrochloride hemihydrate is useful as an antidepressant agent.
    Type: Grant
    Filed: August 19, 1982
    Date of Patent: January 3, 1984
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: Stanford S. Pelosi, Jr., Chia-Nien Yu, Ronald E. White, George C. Wright
  • Patent number: 4403097
    Abstract: 5-(3-Trifluoromethylphenyl)-2-furancarboxylic acid 2-(1-methylethylidene)hydrazide is an effective skeletal muscle relaxant.
    Type: Grant
    Filed: June 4, 1982
    Date of Patent: September 6, 1983
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: Stanford S. Pelosi, Jr., Chia-Nien Yu
  • Patent number: 4393204
    Abstract: 3-[[5-(4-Chlorophenyl)furfurylidene]amino]-5-(substituted)-2-oxazolidinones are useful as antiinflammatory agents.
    Type: Grant
    Filed: May 21, 1982
    Date of Patent: July 12, 1983
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: Stanford S. Pelosi, Jr.
  • Patent number: 4393208
    Abstract: The compound 5-methyl-2-trifluoromethylindolo[2,3-b]quinoxaline is useful as an immunomodulating agent.
    Type: Grant
    Filed: March 29, 1982
    Date of Patent: July 12, 1983
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: Robert J. Alaimo
  • Patent number: 4382140
    Abstract: 2,4-Diphenyl-5-pyrimidinecarbonitrile is useful as an immunomodulating agent.
    Type: Grant
    Filed: January 26, 1982
    Date of Patent: May 3, 1983
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: Thomas J. Schwan
  • Patent number: 4381394
    Abstract: The compound 6,7-dichloro-2-[(1-methyl-2-pyrrolidylidene)amino]-4-thiocyanatobenzothiaz ole is useful as an immunomodulating agent.
    Type: Grant
    Filed: March 29, 1982
    Date of Patent: April 26, 1983
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventor: Robert J. Alaimo
  • Patent number: 4374246
    Abstract: Compounds of the formula: ##STR1## wherein M is hydrogen or sodium andR is hydrogen or ethylare useful as angiotensin I converting enzyme inhibitors.
    Type: Grant
    Filed: June 18, 1981
    Date of Patent: February 15, 1983
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: George C. Wright, Ronald E. White
  • Patent number: 4370313
    Abstract: A nitrofurantoin dosage form comprising a nitrofurantoin salt and excipients therefor enterically coated with an acrylic resin is described.
    Type: Grant
    Filed: October 26, 1981
    Date of Patent: January 25, 1983
    Assignee: Eaton Laboratories, Inc.
    Inventor: William L. Davies
  • Patent number: 4370494
    Abstract: The compound N-(1-carboxy-3-phenylpropyl)glycyl-N'-(2,3-dihydro-1H-indene-1-yl)glycine is useful as an angiotensin I converting enzyme inhibitor.
    Type: Grant
    Filed: January 15, 1982
    Date of Patent: January 25, 1983
    Assignee: Norwich Eaton Pharmaceuticals, Inc.
    Inventors: George C. Wright, Ronald E. White
  • Patent number: 4349677
    Abstract: The compound 3,4-dihydro-3,4-isoquinolinedione 4-oxime is useful as an antifungal agent.
    Type: Grant
    Filed: November 9, 1981
    Date of Patent: September 14, 1982
    Assignee: Morton-Norwich Products, Inc.
    Inventors: Thomas J. Schwan, Homer A. Burch, Joseph E. Gray
  • Patent number: 4339386
    Abstract: Compounds of the formula: ##STR1## wherein R is 4-chlorophenyl, 3,4-dichlorophenyl, or 3,4-dimethoxyphenyl, and R.sub.1 is hydrogen or methylaminocarbonyl with the proviso that when R is 4-chlorophenyl, R.sub.1 is methylaminocarbonyl are useful as antifungal agents.
    Type: Grant
    Filed: August 5, 1981
    Date of Patent: July 13, 1982
    Assignee: Morton-Norwich Products, Inc.
    Inventors: Robert J. Alaimo, Joseph E. Gray
  • Patent number: 4336199
    Abstract: The compound 5-(2,4-dichlorophenyl)-2-furancarboxaldehyde-O-[(methylamino)carbonyl]oxim e is useful as an antifungal agent.
    Type: Grant
    Filed: July 10, 1981
    Date of Patent: June 22, 1982
    Assignee: Morton-Norwich Products, Inc.
    Inventors: Robert J. Alaimo, Joseph E. Gray
  • Patent number: 4335130
    Abstract: A mixture of pyrido[3,4-g]isoquinoline (A) and 3,8-phenanthroline (B) in which the ratio of A:B is 37:63 is useful as an antifungal agent.
    Type: Grant
    Filed: May 12, 1981
    Date of Patent: June 15, 1982
    Assignee: Morton-Norwich Products, Inc.
    Inventors: Thomas J. Schwan, Joseph E. Gray
  • Patent number: 4332735
    Abstract: The compound 5-[3,4-dimethoxyphenyl]-N-{[(methylamino)carbonyl]oxy}-.alpha.-oxo-2-furan ethanimidoyl chloride is useful as an antifungal agent.
    Type: Grant
    Filed: July 6, 1981
    Date of Patent: June 1, 1982
    Assignee: Morton-Norwich Products, Inc.
    Inventors: Robert J. Alaimo, Joseph E. Gray, George M. Klein
  • Patent number: 4291163
    Abstract: Certain decahydroquinoline-2-carboxylic acid compounds are useful as inhibitors of Angiotensin I converting enzyme.
    Type: Grant
    Filed: January 23, 1980
    Date of Patent: September 22, 1981
    Assignee: Morton-Norwich Products, Inc.
    Inventors: George C. Wright, Ronald E. White
  • Patent number: 4281190
    Abstract: A process for preparing N-[2-(p-hydroxyphenyl)ethyl]-p-chlorobenzamide, a penultimate precursor for bezafibrate, is described.
    Type: Grant
    Filed: August 14, 1980
    Date of Patent: July 28, 1981
    Assignee: Morton-Norwich Products, Inc.
    Inventor: Nicholas Harris